Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
University Hospital Southampton NHS Foundation Trust
MultiVir, Inc.
Tel-Aviv Sourasky Medical Center
National Cancer Institute (NCI)
The University of Hong Kong